Open-Label, Proof-of-Concept and Dose Finding Phase 1b/2 Study of VERU-100 in Men With Advanced Prostate Cancer
Latest Information Update: 22 May 2023
At a glance
- Drugs VERU 100 (Primary)
- Indications Prostate cancer
- Focus Proof of concept; Therapeutic Use
- Acronyms VERU-100
- Sponsors Veru Healthcare
- 17 May 2023 Status changed from active, no longer recruiting to discontinued.
- 27 Feb 2023 Status changed from recruiting to active, no longer recruiting.
- 13 Sep 2022 Planned End Date changed from 30 Sep 2022 to 30 Apr 2023.